PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,519 | -40.9% | 37,060 | -28.8% | 0.00% | – |
| Q2 2023 | $104,080 | +956.5% | 52,040 | +1009.4% | 0.00% | – |
| Q1 2023 | $9,851 | +5906.7% | 4,691 | +3809.2% | 0.00% | – |
| Q4 2022 | $164 | -98.5% | 120 | -98.9% | 0.00% | – |
| Q3 2022 | $11,000 | – | 11,118 | +9165.0% | 0.00% | – |
| Q2 2022 | $0 | – | 120 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 120 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 120 | -94.8% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 2,314 | +20.2% | 0.00% | – |
| Q2 2021 | $3,000 | -70.0% | 1,925 | -12.3% | 0.00% | – |
| Q1 2021 | $10,000 | +100.0% | 2,195 | +83.4% | 0.00% | – |
| Q4 2020 | $5,000 | -70.6% | 1,197 | -73.5% | 0.00% | – |
| Q3 2020 | $17,000 | +21.4% | 4,512 | +23.5% | 0.00% | – |
| Q2 2020 | $14,000 | – | 3,653 | +1940.8% | 0.00% | – |
| Q1 2020 | $0 | – | 179 | +258.0% | 0.00% | – |
| Q4 2019 | $0 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spire Wealth Management | 148,800 | $158,000 | 0.00% |
| MEITAV INVESTMENT HOUSE LTD | 244,332 | $257,000 | 0.00% |
| Phoenix Holdings Ltd. | 244,113 | $259,000 | 0.00% |
| IHT Wealth Management, LLC | 24,000 | $25,000 | 0.00% |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
| Virtu Financial LLC | 15,199 | $16,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 41,574 | $44,000 | 0.00% |
| Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 28,790 | $31,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5,153 | $5,000 | 0.00% |